Breast Cancer Market size See Incredible Growth during 2028
Breast cancer is defined as a type of cancer
where a lump is formed in the breast, and red patches appear on the skin when
cells of breast tissue become cancerous. Market Research Future (MRFR) has
published and released a research report about the global breast
cancer market that anticipates great boost with 9.2% CAGR (Compound
Annual Growth Rate) for this market between 2017 and 2023. Observing the market
structure, this report evaluates the future growth potential of the market and
analyzes the approaches of the key players in the market. It also follows the
competitive developments such as joint ventures, new product developments,
mergers and acquisitions, research and developments (R & D) in the market.
The key factors that drive this market
include the adoption of an unhealthy lifestyle, exposure to harmful radiation,
increasing female geriatric population, increasing governmental initiatives,
and increasing number of females suffering from breast cancer. However, there
are some factors that can hamper the growth of this market. Such factors
include adverse effects associated with the therapy, high cost of the
treatment, and long approval time for the drugs.
Get Sample Reports: https://www.marketresearchfuture.com/sample_request/1379
The global Breast cancer Market has been segmented on the basis of end user, treatment,
type, and lastly, region. Based on end users, this market has been segmented
·
on the basis of
hospital pharmacies, private pharmacies,
and others.
·
The treatment-based
segmentation of this market covers
biologic therapy, chemotherapy, hormone therapy, surgery & radiation
therapy, and targeted therapy.
·
Chemotherapy has been further segmented into alkylating agents,
antimetabolites, anthracyclines, and taxanes. The targeted therapy has been
further segmented into monoclonal antibodies and tyrosine kinase inhibitors.
·
By type-based
segmentation, the market has been
segmented into invasive ductal carcinoma, invasive lobular carcinoma, others.
Key Players
The key players in the global Breast
cancer market include
·
Accord
Healthcare, Inc. (India),
·
Actavis Inc.
(USA),
·
Apthera Inc
(UK),
·
Astellas
(Japan),
·
AstraZeneca
(UK),
·
Bayer AG
(Germany),
·
BioNumerik
Pharmaceuticals (USA),
·
Bipar Sciences
(USA),
·
Bristol-Myers
Squibb Company (USA),
·
Eli Lilly and
Company (USA),
·
F. Hoffmann-La
Roche (Switzerland),
·
Genentech (USA),
·
Gilead Sciences
Inc. (USA),
·
GlaxoSmithKline
(UK),
·
Hospira, Inc.
(USA),
·
Novartis AG
(Switzerland),
·
Oncogenex (USA),
·
Oncothyreon Inc
(USA),
·
Pfizer (USA),
·
Puma
Biotechnology (USA),
·
Sanofi S.A.
(USA),
·
Sun
Pharmaceutical Industries Ltd (India), and
·
Teva
Pharmaceutical Industries (Israel).
Segmentation:
The regional segmentation of the global liquid
biopsy breast cancer market segments the
market into regional markets namely The Americas (North America & South
America), Asia Pacific, Europe, and the Middle East & Africa (MEA). The
Americas dominate the global market. Changing lifestyle and increasing
prevalence of breast cancer in the Americas has driven the growth of the
market. In the Americas, North America is a bigger market than South America
because more advanced medical facilities being available in North America and
many key players in the market is based in Canada and the United States of
America (USA).
The second biggest market is in Europe. Due
to the reasons same as The Americas, Western Europe is a bigger market than
Eastern Europe. The most significant country-based markets in Western Europe
are France, Germany, Italy, Spain, and the United Kingdom (UK). Technological
advancement, increased life expectancy and increasing disposable income
regarding healthcare expenditure of people are driving the market growth in the
Americas and Europe.
According to the report, Asia Pacific is
expected to emerge as the fastest growing market during the forecast period.
The most significant country-specific markets in the Asia Pacific region are
Australia, China, Japan, and South Korea, followed by the rest of Asia Pacific.
MEA region is a small market. The market is low due to lack of awareness, lack
of education, lack of technological development, political instability, poor
healthcare, and healthcare not considered a priority by most governments. The
most important country-specific markets in this region are Kuwait, Oman, Saudi
Arabia, Qatar, and the United Arab Emirates (UAE).
TABLE
OF CONTENTS
1 INTRODUCTION
·
1.1 DEFINITION
·
1.2 SCOPE OF STUDY
·
1.2.1 RESEARCH OBJECTIVE
·
1.2.2 ASSUMPTIONS & LIMITATIONS
·
1.2.2.1 ASSUMPTIONS
·
1.2.2.2 LIMITATIONS
·
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
·
2.1 RESEARCH PROCESS:
·
2.2 PRIMARY RESEARCH
·
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
·
3.1 DRIVERS
·
3.2 RESTRAINTS
·
3.3 OPPORTUNITIES
·
3.4 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
·
4.1 PORTERS FIVE FORCES MODEL
·
4.2 BARGAINING POWER OF SUPPLIERS
·
4.3 BARGAINING POWER OF BUYERS
·
4.4 THREAT OF NEW ENTRANTS
·
4.5 THREAT OF SUBSTITUTES
·
4.6 INTENSITY OF RIVALRY
5. GLOBAL BREAST CANCER
MARKET, BY TYPE
·
5.1 INVASIVE DUCTAL CARCINOMA
·
5.2 INVASIVE LOBULAR CARCINOMA
·
5.3 OTHER
TOC will be continue..
Latest Industrial News
·
Roberta Lombardi,
founder, and CEO of Infinite Beauty has designed a new bra to make breast
cancer patients feel normal. 11 SEP 2018
·
Biotechnology Company,
Oncolytic Biotech, has announced a clinical collaboration with an academic
research group. This collaboration is dedicated to clinical and translational
research in breast cancer, SOLTI. 11 SEP 2018
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York
10013
Comments
Post a Comment